Program
Thursday, June 6
15:00-15:05 Opening Remarks
15:05-15:45 Keynote Lecture 1
(TBA)
Seishi Ogawa (Kyoto Univ.)
15:45-17:00 Medical AI / Mathematical Simulation
Understanding Cancer Diversity by Quantitative Representation of Histopathology
Shumpei Ishikawa (Univ. of Tokyo / Natl. Cancer Center)
Integration of deep learning and mathematical modeling unveil the dynamics of tumor microenvironment
Yasuhiro Kojima (Natl. Cancer Center)
Data-driven and AI-driven cancer research
Ryuji Hamamoto (Natl. Cancer Center)
18:00-20:00 Welcome Party (Presenter (oral & poster) only)
Friday, June 7
9:00-9:40Keynote Lecture 2
(TBA)
Marc Ladanyi (Memorial Sloan Kettering Cancer Center)
9:40-10:30 Epigenetic Regulation (1)
Therapeutic Approaches for Cancer and Sarcoma Targeting RNA Binding Proteins
Akihide Yoshimi (Natl. Cancer Center)
Exploring Chromatin Remodeling in Malignant Hematopoiesis
Daichi Inoue (Osaka Univ.)
10:30-10:40 Coffee Break
10:40-11:35 Epigenetic Regulation (2)
Epigenetic regulation of Dynamic Interplay between Tumor Microenvironment and Cancer Cell
Yutaka Kondo (Nagoya Univ.)
Topological formation of transcriptional condensates relative to subnuclear compartments
Won-Ki Cho (Korea Advanced Institute of Science and Technology, Korea)
11:35-12:30 Precision Cancer Medicine (1)- Prevetion -
(TBA)
Dr. Shuji Ogino (Harvard University, Brigham and Women’s Hospital, Broad Institute of MIT and Harvard)
(TBA)
Yukari Totsuka (School of Phamacy, Nihon Univ)
12:30-13:30 Luncheon Seminar 1
13:30-14:50 Cellular Senescence
Interplay between cancer stromal senescent cells determines malignant microenvironment.
Makoto Nakanishi (Univ. of Tokyo)
Pros and Cons of senescence in cancer
Andrea Alimonti (Institute of Oncology Research Dept. Health Sci.Tech., ETH Zurich)
Regulation of cancer and aging by aging-responsible cells
Tatsushi Igaki (Kyoto Univ)
14:50-15:05 Coffee Break
15:05−15:55Sweets Seminar
15:55-17:10 Tumor microenvironment (1)
Multi-Layered transcriptional architecture of glioblastoma ecosystems revealed by large scale-single nucleus RNA sequencing
Masashi Nomura (Univ. of Tokyo)
Immunne cells derived from clonal hematopoiesis shape the tumor microenvironments
Mamiko Sakata-Yanagimoto (Tsukuba Univ.)
Genetic alterations characterize the tumor immune microenvironment
Shohei Koyama (Osaka Univ./NCC)
18:00-20:00 Dinner (all participants)
Saturday, June 8
9:00-10:45 Tumor Heterogeneity
Strategic drug development using in vitro and in vivo screening to overcome cancer heterogeneity
Shinji Kohsaka (Natl. Cancer Center)
Heterogenous metastatic breast cancer stem cells reside in the metastatic niche
Noriko Gotoh (Kanazawa Univ.)
Survival signaling of drug-tolerant persister cells and mechanisms of acquired resistance emergence
Ryohei Katayama (Cancer Institute)
(TBA)
Clare Weeden (The Francis Crick Inst., UK)
10:45-10:55 Coffee Break
10:55-11:35 Keynote Lecture 3
(TBA)
Hiroyoshi Nishikawa (National Cancer Center, Japan)
11:35-12:30 Tumor microenvironment (2)
Gut-liver Axis-Mediated Mechanism of Steatosis-Associated Hepatocellular Carcinoma Progression
Naoko Ohtani (Osaka Metropolitan Univ.)
Gut and tumor microbiota as a biomarker and therapeutic target in lung cancer: A new strategy in precision medicine
Arielle Elkrief (Univ. of Montreal)
12:30-13:30 Luncheon Seminar 2
13:30-14:45Poster Session (includes coffee break)
14:45-16:30 Precision Cancer Medicine (2)
CGP test and Cancer genomic medicine in Japan
Kuniko Sunami (Natl. Cancer Center)
Investigating the selective mechanism behind U2AF1 mutations in lung adenocarcinoma
David Walter (Dana Farber Cancer Institute, USA)
Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases
Keisuke Kataoka (Keio Univ.)
Regulation of cytokine signaling for improved adoptive immunotherapy
Yuki Kagoya (Keio Univ.)
